This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: David Wettlauper: Innovator in Pharmaceuticals
Introduction
David Wettlauper is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on substituted benzenesulfonylureas and thioureas. His research has led to advancements in the preparation and application of these compounds in medical treatments.
Latest Patents
Wettlauper holds 1 patent for his invention titled "Substituted benzenesulfonylureas and thioureas-process for their preparation and their use as pharmaceuticals." This patent highlights his expertise in developing new pharmaceutical compounds that can potentially improve patient outcomes.
Career Highlights
Throughout his career, David Wettlauper has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Hoechst has allowed him to collaborate with other talented professionals and contribute to groundbreaking research in drug development.
Collaborations
Wettlauper has worked alongside esteemed colleagues such as Heinrich Christian Englert and Dieter Mania. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
David Wettlauper's contributions to the pharmaceutical industry through his innovative patents and collaborations underscore his importance as an inventor. His work continues to influence the development of new medical treatments, showcasing the impact of innovation in healthcare.